JNJ

Johnson & Johnson

Healthcare
Drug Manufacturers - General
$640.02B market cap

Forecast run · Sep 14, 2026Upside rank 2987 of 3,136

Model Signal

ForecastQ Daily Probabilities

5.9%

44.7%

2.7%

Analyst Consensus

Recommendation2.55/5 Hold

Last price$265.58

Price target$286.93

Implied move+8.0%

Analysts40

ForecastQ Portfolios

JNJ is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.